BLOOD OPTIMIZATION PROGRAM - BOP
Dead / Cancelled — Cancelled — Section 8 (as of 02 Apr 2013)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78330843
- Registration number
- 3142907
- Mark type
- Stylized text
- Filed
- 20 Nov 2003
- Published for opposition
- 15 Nov 2005
- Registered
- 12 Sept 2006
- Attorney of record
- Howard N. Aronson
Goods and services
- Class 044 — Medical, beauty and agricultural services: Medical services in the nature of blood transfusion therapy, namely, blood volume measurement, providing transfusions using autologous blood, synchronization of blood volume measurement and therapy with bone marrow stimulants to enable blood storage prior to a potential blood transfusion in individuals undergoing surgery in a pre-operative state and in a post-operative state
Owner
- Daxor Corporation, New York, NY, US
- Daxor Corporation, New York, NY, US
- Daxor Corporation, New York, NY, US
Prosecution history
- 02 Apr 2013 — CANCELLED SEC. 8 (6-YR)
- 19 Sept 2012 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 19 Sept 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Aug 2012 — TEAS SECTION 8 & 15 RECEIVED
- 12 Sept 2006 — REGISTERED-PRINCIPAL REGISTER
- 26 Jul 2006 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 24 Jul 2006 — ASSIGNED TO LIE
- 29 Jun 2006 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Apr 2006 — ASSIGNED TO LIE
- 06 Apr 2006 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Mar 2006 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Feb 2006 — USE AMENDMENT FILED
- 28 Feb 2006 — TEAS STATEMENT OF USE RECEIVED
- 07 Feb 2006 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 15 Nov 2005 — PUBLISHED FOR OPPOSITION